Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxel.

Mecca C, Ponzetti A, Caliendo V, Ciuffreda L, Lista P.

Eur J Dermatol. 2012 Nov-Dec;22(6):758-61. doi: 10.1684/ejd.2012.1845.

PMID:
23131415
2.

Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.

Herbst RS, Arquette M, Shin DM, Dicke K, Vokes EE, Azarnia N, Hong WK, Kies MS.

J Clin Oncol. 2005 Aug 20;23(24):5578-87. Epub 2005 Jul 11.

PMID:
16009949
3.

Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck.

Kim S, Eleff M, Nicolaou N.

Head Neck. 2011 Feb;33(2):286-8. doi: 10.1002/hed.21299.

PMID:
19953623
4.
5.

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R.

N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656.

6.

Efficacy of cetuximab in the treatment of squamous cell carcinoma.

Preneau S, Rio E, Brocard A, Peuvrel L, Nguyen JM, Quéreux G, Dreno B.

J Dermatolog Treat. 2014 Oct;25(5):424-7. doi: 10.3109/09546634.2012.751481. Epub 2013 Feb 3.

PMID:
23167307
7.

Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM.

Semin Oncol. 1998 Apr;25(2 Suppl 4):40-4; discussion 45-8.

PMID:
9578061
8.

Platinum and anthracycline therapy for advanced cutaneous squamous cell carcinoma.

Nakamura K, Okuyama R, Saida T, Uhara H.

Int J Clin Oncol. 2013 Jun;18(3):506-9. doi: 10.1007/s10147-012-0411-y. Epub 2012 Apr 26.

PMID:
22534799
9.

Durable complete response induced by paclitaxel-nimotuzumab-methotrexate chemotherapy in a patient with metastatic head and neck squamous cell carcinoma.

Verduzco-Rodríguez L, Aguirre-González EH, Verduzco-Aguirre HC.

Hematol Oncol Stem Cell Ther. 2011;4(4):182-4. doi: 10.5144/1658-3876.2011.182.

10.

A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.

Zhang X, Shen L, Li J, Li Y, Li J, Jin M.

Am J Clin Oncol. 2008 Feb;31(1):29-33. doi: 10.1097/COC.0b013e3181131ca9.

PMID:
18376224
11.

Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04).

Iranzo V, Sirera R, Carrato A, Cabrera A, Jantus E, Guijarro R, Sanmartín E, Blasco A, Gil M, Gómez-Aldaraví L, González-Larriba JL, Massuti B, Velasco A, Provencio M, Rossell R, Camps C.

Clin Transl Oncol. 2011 Jun;13(6):411-8.

PMID:
21680302
12.

Paclitaxel and cetuximab combination efficiency after the failure of a platinum-based chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma.

Péron J, Ceruse P, Lavergne E, Buiret G, Pham BN, Chabaud S, Favier B, Girodet D, Zrounba P, Ramade A, Fayette J.

Anticancer Drugs. 2012 Oct;23(9):996-1001. doi: 10.1097/CAD.0b013e32835507e5.

PMID:
22643048
13.

Giant neglected squamous cell carcinoma of the skin.

Ricci F, Paradisi A, Fossati B, Mancini M, Curatolo P, Guerriero C, Capizzi R.

Dermatol Ther. 2015 Jul-Aug;28(4):230-4. doi: 10.1111/dth.12214. Epub 2015 Mar 5.

PMID:
25754304
14.

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.

Loibl S, Murmann C, Schwedler K, Warm M, Müller L, Heinrich G, Nekljudova V, von Minckwitz G.

Cancer Chemother Pharmacol. 2009 Apr;63(5):953-8. doi: 10.1007/s00280-008-0821-8. Epub 2008 Aug 21.

PMID:
18716777
15.

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma.

Shin DM, Khuri FR, Glisson BS, Ginsberg L, Papadimitrakopoulou VM, Clayman G, Lee JJ, Ang KK, Lippman SM, Hong WK.

Cancer. 2001 Apr 1;91(7):1316-23.

PMID:
11283932
16.

[Phase II study of paclitaxel and cisplatin for advanced squamous-cell carcinoma of esophagus].

Huang J, Cai RG, Meng PJ, Zhang MJ, Cui CX, Yang L, Chu DT, Sun Y, Wang JW.

Zhonghua Zhong Liu Za Zhi. 2004 Dec;26(12):753-5. Chinese.

PMID:
15733398
17.

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.

Kosmas C, Tsavaris N, Vadiaka M, Stavroyianni N, Koutras A, Malamos N, Onyenadum A, Rokana S, Polyzos A, Kalofonos HP.

Cancer. 2001 Dec 1;92(11):2902-10.

PMID:
11753965
18.
19.

Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman SM.

Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-33-S19-37.

PMID:
9427263
20.

Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.

Baselga J, Trigo JM, Bourhis J, Tortochaux J, Cortés-Funes H, Hitt R, Gascón P, Amellal N, Harstrick A, Eckardt A.

J Clin Oncol. 2005 Aug 20;23(24):5568-77. Epub 2005 Jul 11.

PMID:
16009950

Supplemental Content

Support Center